Suzhou, China

Henry Li

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Crown Bioscience (Suzhou) Inc.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Henry Li. Retrieved from https://idiyas.com/inventor/henry-li-b6smg6yo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Henry Li

Introduction

Henry Li is a notable inventor based in Suzhou, China. He has made significant contributions to the field of biotechnology, particularly in the identification of tumor models. His work is essential for advancing cancer research and treatment methodologies.

Latest Patents

Henry Li holds a patent titled "Methods and compositions for identification of tumor models." This patent provides methods and compositions, such as kits, for identifying or authenticating a sample, specifically a tumor model, based on the genotype of the sample at a group of SNP loci. He has 1 patent to his name, showcasing his innovative approach to solving complex problems in medical science.

Career Highlights

Henry Li is currently employed at Crown Bioscience (Suzhou) Inc., where he continues to develop and refine his research. His work at this company allows him to collaborate with other experts in the field, enhancing the impact of his inventions.

Collaborations

Henry Li works alongside his coworker, Xiaobo Chen, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Henry Li's contributions to the field of biotechnology, particularly through his patent on tumor model identification, highlight his role as an influential inventor. His work at Crown Bioscience (Suzhou) Inc. continues to pave the way for advancements in cancer research and treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…